Connect with us
European Gaming Congress 2024

Artificial Intelligence

Aledade Adds More Than 450 New Practices for 2023, Making It the Largest Network of Independent Primary Care in the Country

Published

on

<!– Name:DistributionId Value:8752095 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1260093 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:a3a3f682-ac11-484e-9442-5970d31099a6 –>

Bethesda, MD, Feb. 21, 2023 (GLOBE NEWSWIRE) — Aledade, the nation’s largest network of independent primary care, today announced that it added more than 450 primary care practices, including nearly 60 health centers, to its nationwide network for 2023, the most of any value-based care practice network. The company continues to be the largest network of independent primary care in the country, with more than two million patients covered by more than 150 value-based contracts across Medicare, Medicare Advantage, Medicaid and commercial payers. Aledade works with more than 1,500 independent primary care practices and health centers – up from more than 1,000 practices in 2022 – including more than 5,000 physicians and 15,000 clinicians across 45 states and the District of Columbia. And thanks to its product and technology, the company is able to grow even further while reproducing at scale the outcomes it has delivered for practices and their patients.

To support Aledade’s large and rapidly growing network and further enhance its ability to scale with quality, Aledade also announced that it has acquired Curia, a leader in value-based care analytics using practical applications of artificial intelligence (AI) to optimize the targeting of patient care and engagement programs. The acquisition will enhance Aledade’s ability to extract valuable insights from disparate data sources, provide more accurate predictions using past data and optimize primary care workflows through cutting-edge AI algorithms.

“We launched Aledade with the goal of building a health care system that works better for patients, practices and all of society. We are the largest network of independent primary care practices, with millions of patients all across the country getting better care from a primary care physician thanks to our success in using advanced predictive analytics and tech-enabled workflows to better identify patients who would benefit the most from particular interventions. But we are just getting started,” said Dr. Farzad Mostashari, CEO and Co-Founder of Aledade. “The team at Curia is drawn by that same mission and our work with them has proven that, together, we’re going to make a real and lasting impact for the practices we serve and their patients.” 

Curia leverages AI and machine learning to automate the core analytical processes needed to identify risk gaps, predict the likelihood of adverse health outcomes like preventable hospitalizations and optimize the targeting of care and engagement programs. Aledade’s acquisition of Curia follows a successful pilot leveraging Curia’s technology and talented team of data scientists, software engineers and business strategists in the targeting of comprehensive advance care planning (CACP) services to the patients who need them most. Using the predictive algorithm developed by Curia, Aledade was able to identify more than 8,000 patients facing the highest risk for mortality in the next two years and work with primary care practices in its national network to enroll these patients in a CACP facilitation. Aledade is exploring even more use cases that will bring targeted care interventions directly to the patients who need them.

Advertisement

“The future of health care isn’t on the horizon; it’s here – in value based care, population health, artificial intelligence and empowered primary care,” said Jim Manzi, founder and Partner at Foundry.ai, the technology studio responsible for building Curia. “That mission is what attracted our team of world-class talent to Curia, and it’s why we were able to work so well with our colleagues at Aledade and improve care for thousands of patients. We share a common mission, and I can’t wait to see what this team will accomplish as one.”

To solidify its commitment to creating a health care system that is good for patients, good for practices and good for society, Aledade recently became a Public Benefit Corporation, a corporate structure that requires the company to weigh the interests of its primary care practice partners, their patients, its employees and those who bear the burden of rising health care costs, alongside those of its shareholders, in all decision making. 

About Aledade

Aledade, a public benefit corporation, is the largest network of independent primary care in the country, helping independent practices, health centers, and clinics deliver better care to their patients and thrive in value-based care. Through its proven, scalable model, which includes cutting-edge data analytics, user-friendly guided workflows, health care policy expertise, strong payer relationships, and integrated care solutions delivered through Aledade Care Solutions, Aledade empowers physicians to succeed financially by keeping people healthy. Together with more than 1,500 practices in 45 states and the District of Columbia, Aledade shares in the risk and reward across more than 150 value-based contracts representing more than 2 million patient lives under management. To learn more, visit www.aledade.com or follow on Twitter, Facebook or LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

Advertisement

This press release contains forward-looking statements, relating to, among other things, our business and growth plans and expectations. Forward-looking statements often include words such as “will,” “may,” “could,” “expect,” “intend,” “believe,” “plan,” “target,” “estimate,” “outlook,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms, and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions, and undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements.


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Invitation to the presentation of ASSA ABLOY’s Q3 report on 23 October starting at 09:00am (CEST)

Published

on

invitation-to-the-presentation-of-assa-abloy’s-q3-report-on-23-october-starting-at-09:00am-(cest)

STOCKHOLM, Oct. 1, 2024 /PRNewswire/ — ASSA ABLOY will release its Q3 report 2024 on Wednesday 23 October 2024 at 08:00 am (CEST). A conference call and webcast will be held following the release of the results, starting at 09:00 am (CEST) and continuing until 10:00 am (CEST). The presentation will be hosted by Nico Delvaux, President & CEO, and Erik Pieder, CFO, followed by questions and answers.

Slides used during the presentation will be available shortly after the release of the report on our website.
Enter the conference call and download presentation material at:assaabloy.com/investors
The details for participation by telephone are as follows:
Participants in Sweden should call +46 8 5051 00 31Participants in UK/Europe should call +44 207 107 06 13Participants in US should call +1 631 570 56 13Other international numbers available HEREFor more information, please contact:Isabelle Ewerlöf, Investor Relations Officer, tel: +46 8 506 485 74
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/assa-abloy/r/invitation-to-the-presentation-of-assa-abloy-s-q3-report-on-23-october-starting-at-09-00am–cest-,c4044794
The following files are available for download:
https://mb.cision.com/Public/7333/4044794/87a98230b5054c2e.pdf
Q3 invitation
 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-assa-abloys-q3-report-on-23-october-starting-at-0900am-cest-302263614.html

Continue Reading

Artificial Intelligence

Breaking barriers in Operational Technology: Meet Treon Connect

Published

on

breaking-barriers-in-operational-technology:-meet-treon-connect

TAMPERE, Finland, Oct. 1, 2024 /PRNewswire/ — Treon, a leader in IoT technology launches Treon Connect, a platform designed to tackle challenges in operational technology (OT). Founded by innovators with a background in ‘connecting people,’ Treon has evolved to focus on connecting operations, leveraging its expertise in IoT and data acquisition.

Despite industrial digitalization progress, physical operations still face significant challenges. Treon Connect is built to overcome these obstacles, offering businesses the tools to enhance operational efficiency and sustainability.
“Siloed vertical solutions hinder scalability, increase costs and enforce manual workflows” said Joni Korppi, CEO of Treon. “At Treon, we developed Treon Connect to address these challenges, drawing on our experience in delivering IoT solutions for large-scale deployments with 150+ customers, including 50 global leaders.”
Treon Connect works alongside customers’ existing systems, enabling data-driven automation, and helping organizations improve operations by:
Enhancing efficiency: Reducing operational costs and extending asset lifespan through increased uptime and optimal use.Prioritizing worker safety: Reducing downtime and providing safer, more controlled environments.Seamless integration: Integrates with existing IT and OT systems.Minimizing environmental impact: Sustainable products that cut emissions, boost energy efficiency, and reduce waste.As part of Treon Connect, Treon launches:
Treon Apex applications for Condition Monitoring, Fleet Management, Network & Device Management, and Events for workflow automation.Treon Aito, the middleware that securely bridges applications, databases, and systems, is now available on cloud or on-premise, expanding support to third-party devices.Treon Industrial Node X, Treon’s latest wireless vibration sensor, offering market-leading capabilities, such as support for variable-speed machinery and a replaceable battery for sustainabilityTreon Gateway 2, a powerful edge computer, has been updated with cellular coverage for the USA, and telematics support for heavy equipment.Treon will launch Treon Connect at SMRP Annual Conference, October 7-10, 2024, in Orlando, FL, where they will showcase their latest innovations and continue introducing new use cases to enhance operations at a rapid pace together with ecosystem partners.
Visit treon.fi/treon-connect
About Treon
Treon is a leading technology company with a mission to help businesses improve productivity, enhance operational visibility, and sustainability. Its platform, Treon Connect, boosts operational efficiency by utilizing data-driven automation to extend machine lifespan, monitor assets, increase productivity, and ensure safety across industries. Treon is trusted by global leaders to provide secure, customized products that integrate seamlessly into existing business solutions.
Press inquiries
Samah Zain, Senior Growth [email protected]+358-505507331
Photo – https://mma.prnewswire.com/media/2519329/Treon_Connect.jpgLogo – https://mma.prnewswire.com/media/2519328/Treon_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/breaking-barriers-in-operational-technology-meet-treon-connect-302262739.html

Continue Reading

Artificial Intelligence

dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

Published

on

dsm-firmenich-completes-the-sale-of-its-meg-3-fish-oil-business-to-kd-pharma-group-sa

KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, Oct. 1, 2024 /PRNewswire/ — dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale and transfer of its MEG-3® fish oil business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production facilities in Piura, Peru and Mulgrave, Canada. 

As part of the transaction, dsm-firmenich received a minority stake of 29% in KD Pharma’s parent company MidCo Omega GmbH. 
The sale and transfer of the business was announced on July 18, 2024. Financial details of the transaction will not be disclosed. 
About dsm-firmenichAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com 
For more information
Media relationsRobin Roothanstel. +41 (0)79 280 03 96e-mail [email protected] 
Investor relationsDave Huizingtel. +31 (0)88 425 7306e-mail [email protected]
Forward-looking statementsThis press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
Logo – https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/dsm-firmenich-completes-the-sale-of-its-meg-3-fish-oil-business-to-kd-pharma-group-sa-302262469.html

Continue Reading

Trending